Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

ABSTRACT: A phase 1, open-label, dose escalation and expansion study of PF-07062119 in patients with selected advanced or metastatic gastrointestinal tumors

DISEASE(S): Gastrointestinal Tumors,Adenocarcinoma,Gastrointestinal Neoplasms,Esophageal Adenocarcinomas,Colorectal Adenocarcinomas,Colorectal Cancer,Gastric Cancer,Esophageal Cancer,Advanced Gastrointestinal Tumors,Gastric Adenocarcinomas,Digestive System Neoplasms

PROVIDER: 2322545 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR